Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, ...

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United ...

Platelet-derived growth factors can restore the proliferative potential of senescent cells taken from the degenerated intervertebral discs of aged humans.

Highridge Medical licensed the U.S. rights for the activL lumbar artificial disc implant, according to a July 8 news release. The company is “imminently” beginning production for the launch of its ...

Spine tech developer Highridge Medical said it is commencing production "imminently" to launch the product later this year.

Most Americans will experience back pain at some point — and many times it’s not a result of injury or illness.

At the Neurosurgery & Spine Group (NSG), based in Los Angeles, neurosurgeons Dr. Jared Ament and Dr. Amir Vokshoor have ...

Intervertebral disc degeneration (IDD) is a prevalent and debilitating condition that affects millions worldwide, leading to chronic back pain and a reduced quality of life. This review shifts the ...